Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia

被引：0
|
作者：
Langabeer, Stephen E. [1 ]
McCarron, Sarah L. [1 ]
Haslam, Karl [1 ]
Preston, Lisa [1 ]
机构：
[1] St James Hosp, Canc Mol Diagnost, Dublin 8, Ireland
来源：
CLINICAL LABORATORY | 2016年 / 62卷 / 05期
关键词：
chronic myeloid leukemia; tyrosine kinase inhibitors; BCR-ABL1 kinase domain mutations; EUROPEAN LEUKEMIANET; CHRONIC PHASE; RECOMMENDATIONS; INHIBITORS; GUIDELINES;
D O I：
10.7754/Clin.Lab.2015.150938
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：975 / 976
页数：2
相关论文
共 50 条
  • [31] Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
    O'Hare, Thomas
    Eide, Christopher A.
    Deininger, Michael W. N.
    [J]. BLOOD, 2007, 110 (07) : 2242 - 2249
  • [32] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [33] Distribution of BCR-ABL1 Transcript Variants in Nigerians with Chronic Myeloid Leukemia
    Owojuyigbe, Temilola O.
    Durosinmi, Muheez A.
    Bolarinwa, Ramoni A. A.
    Salawu, Lateef
    Akinola, Norah O.
    Ademosun, Abdulwaheed A.
    Bosede, Oluwayomi T.
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2020, 36 (04) : 646 - 651
  • [34] BCR-ABL1 negative chronic myeloid leukemia: report of two cases
    Figueroa-Faundez, Fernanda
    Vidal-Rojas, Catalina
    Briones-Munoz, Vania
    Chandia-Cabas, Mauricio
    [J]. REVISTA MEDICA DE CHILE, 2022, 150 (03) : 397 - 401
  • [35] Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
    Abu Seman, Zahidah
    Ahid, Fadly
    Kamaluddin, Nor Rizan
    Sahid, Ermi Neiza Mohd
    Esa, Ezalia
    Said, Siti Shahrum Muhamed
    Azman, Norazlina
    Mat, Wan Khairull Dhalila Wan
    Abdullah, Julia
    Ali, Nurul Aqilah
    Khalid, Mohd Khairul Nizam Mohd
    Yusoff, Yuslina Mat
    [J]. BMC RESEARCH NOTES, 2024, 17 (01)
  • [36] BCR-ABL1 Kinase Domain Mutations in Front-Line Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients in India: A Single Laboratory Experience
    Majumdar, Atreye
    Gupta, Aastha
    Katara, Rahul
    Mishra, Avshesh
    Singh, Aayushi
    Sharma, Deepak
    Shrivastava, Aman
    Sharma, Shivani
    Mohanty, Sambit
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 870 - 873
  • [37] BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib
    Benjamin, Esther Sathya Bama
    Ravindra, Niveditha
    Rajamani, Bharathi Murugan
    Anandan, Senthamizhselvi
    Kausalya, Bagavathi
    Veldore, Vidya
    Mathews, Vikram
    Velayudhan, Shaji Ramachandran
    Balasubramanian, Poonkuzhali
    [J]. LEUKEMIA & LYMPHOMA, 2021, 62 (06) : 1528 - 1531
  • [38] BCR-ABL1 Kinase Domain Mutations in Front-Line Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients in India: A Single Laboratory Experience
    Majumdar, Atreye
    Gupta, Aastha
    Katara, Rahul
    Mishra, Avshesh
    Singh, Aayushi
    Sharma, Deepak
    Shrivastava, Aman
    Sharma, Shivani
    Mohanty, Sambit
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 870 - 873
  • [39] BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?
    Soverini, Simona
    Martelli, Margherita
    Bavaro, Luana
    [J]. LANCET HAEMATOLOGY, 2019, 6 (05): : E236 - E237
  • [40] BCR-ABL Mutations in Chronic Myeloid Leukemia
    Ernst, Thomas
    La Rosee, Paul
    Mueller, Martin C.
    Hochhaus, Andreas
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
12345